Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam besylate vs propofol for painless gastrointestinal endoscopy in elderly patients
ChiCTR2500110081Phase 4Not yet recruiting
- Sponsor
- Beijing Friendship Hospital
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam (4 arms), sponsored by Beijing Friendship Hospital. Primary endpoints: Median effective dose for successful gastroscope insertion (Trial I) and Incidence of hypoxemia (Trial II primary). Planned start Sep 2025; status: not yet recruiting.
02
Drugs
remimazolam
Beyond the preview
Go deeper on ChiCTR2500110081.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500110081.